These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4340658)

  • 1. The "switch process" in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs.
    Bunney WE; Goodwin FK; Murphy DL; House KM; Gordon EK
    Arch Gen Psychiatry; 1972 Sep; 27(3):304-9. PubMed ID: 4340658
    [No Abstract]   [Full Text] [Related]  

  • 2. Catecholamine metabolism of manic-depressive illness.
    Takahashi R; Nagao Y; Tsuchiya K; Takamizawa M; Kobayashi T; Toru M; Kobayashi K; Kariya T
    J Psychiatr Res; 1968 Dec; 6(3):185-99. PubMed ID: 5731854
    [No Abstract]   [Full Text] [Related]  

  • 3. The switch process from depression to mania: relationship to drugs which alter brain amines.
    Bunney WE; Murphy DL; Goodwin FK; Borge GF
    Lancet; 1970 May; 1(7655):1022-7. PubMed ID: 4191630
    [No Abstract]   [Full Text] [Related]  

  • 4. [Catecholamine metabolism in manic-depressive psychosis].
    Usherenko LS
    Fiziol Zh; 1970; 16(3):393-9. PubMed ID: 5509683
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and pharmacological investigations of the psychobiology of the affective disorders.
    Murphy DL; Goodwin FK; Bunney WE
    Int Pharmacopsychiatry; 1971; 6(3):137-46. PubMed ID: 4150691
    [No Abstract]   [Full Text] [Related]  

  • 6. [The relationship of the metabolism of biogenic amines to affective pathology in chronic alcoholism].
    Skugarevskaia EI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):896-9. PubMed ID: 5364242
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychobiological and pharmacological studies of manic-depressive illness.
    Bunney WE; Gershon ES; Murphy DL; Goodwin FK
    J Psychiatr Res; 1972 Sep; 9(3):207-26. PubMed ID: 5083175
    [No Abstract]   [Full Text] [Related]  

  • 8. Excretion of catecholamines and tryptophan derivatives in schizophrenia.
    Mileikovskii YA
    Neurosci Behav Physiol; 1979; 9(4):325-8. PubMed ID: 158714
    [No Abstract]   [Full Text] [Related]  

  • 9. Regular induction of hypomania by L-dopa in "bipolar" manic-depressive patients.
    Murphy DL; Brodie HK; Goodwin FK; Bunney WE
    Nature; 1971 Jan; 229(5280):135-6. PubMed ID: 4321339
    [No Abstract]   [Full Text] [Related]  

  • 10. Deductive approaches to the catecholamine hypothesis of affective disorders.
    Wittenborn JR
    J Nerv Ment Dis; 1974 May; 158(5):320-4. PubMed ID: 4823932
    [No Abstract]   [Full Text] [Related]  

  • 11. Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate.
    Greenspan K; Schildkraut JJ; Gordon EK; Baer L; Aronoff MS; Durell J
    J Psychiatr Res; 1970 Feb; 7(3):171-83. PubMed ID: 5440858
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of aminazine on the excretion of adrenaline noradrenaline, dopamine and dopa in healthy subjects and in the manic phase of manic-depressive psychosis].
    Matlina ESh; Osipova MS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(1):128-31. PubMed ID: 5448719
    [No Abstract]   [Full Text] [Related]  

  • 13. [A comprehensive method of determining catecholamines, DOPA and 5-hydroxyindoleacetic acid in urine].
    Nikiragina GP; Khoreva SA
    Lab Delo; 1988; (9):8-11. PubMed ID: 2461495
    [No Abstract]   [Full Text] [Related]  

  • 14. The continuum model as a resolution of paradoxed in manic-depressie psychosis.
    Court JH
    Br J Psychiatry; 1972 Feb; 120(555):133-41. PubMed ID: 5043718
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biochemistry of depression].
    Matussek N
    J Neural Transm; 1972; 33(3):223-34. PubMed ID: 4565920
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biogenic amines in chronic pancreatitis].
    Geller LI; Kazimirchik AP; Amatniak AG; Kontsevaia NG
    Vopr Med Khim; 1973; 19(6):570-3. PubMed ID: 4212567
    [No Abstract]   [Full Text] [Related]  

  • 17. 5-Hydroxytryptamine metabolism in affective illness: the effect of tryptophan administration.
    Ashcroft GW; Crawford TB; Cundall RL; Davidson DL; Dobson J; Dow RC; Eccleston D; Loose RW; Pullar IA
    Psychol Med; 1973 Aug; 3(3):326-32. PubMed ID: 4729192
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of amantadine on the urinary excretion of some monoamines and metabolites in normal and Parkinsonian subjects.
    Jones DG; Turnbull MJ; Lenman JA; Robertson MA
    J Neurol Sci; 1972 Nov; 17(3):245-53. PubMed ID: 4653961
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuropsychopharmacology and the affective disorders. (Third of three parts).
    Schildkraut JJ
    N Engl J Med; 1969 Aug; 281(6):302-8 concl. PubMed ID: 4894568
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and biochemical aspects of lithium therapy.
    Clower CG; Savage C; Messiha F
    Dis Nerv Syst; 1971 Feb; 32(2):127-30. PubMed ID: 5547037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.